Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats.
Using flow cytometry with the excimer-forming lipid technique with pyrenedecanoic acid, we measured membrane fluidity of polymorphonuclear leukocytes (PMNs) from 20 streptozocin (STZ)-induced diabetic rats. Diabetes mellitus was induced in male Sprague-Dawley rats (body wt 243 +/- 11 g) with an injection of 25 mg/kg i.v. STZ. Membrane fluidity of PMNs was significantly lower at 2 wk after the STZ injection when serum glucose reached the plateau (31.1 +/- 5.8 mM), and after 3 wk, membrane fluidity remained unchanged. In 7 STZ-resistant rats for which serum glucose was less than 10 mM at 2 wk after the STZ injection, gradual normalization in membrane fluidity was observed. PMN membrane fluidity at each week correlated inversely with respective serum glucose levels 1 wk previously (r = -0.76) but not with serum lipid levels. Cross-incubation studies ascribed this observation to factors in the diabetic rat serum. Glycosylated protein, which was separated from diabetic rat serum, decreased membrane fluidity of control rat PMNs. Human diabetic subjects have an increased risk for infection, which may be due partly to altered membrane fluidity of their PMNs.
Masuda
M
M
Department of Clinico-Laboratory Medicine, Kansai Medical University, Osaka, Japan.
Murakami
T
T
Egawa
H
H
Murata
K
K
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002462:Cell Membrane / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D004351:Drug Resistance; D008297:Male; D008560:Membrane Fluidity; D008562:Membrane Glycoproteins / Q000097:blood; D009504:Neutrophils / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013311:Streptozocin / Q000494:pharmacology
D001786:Blood Glucose; D008562:Membrane Glycoproteins; D013311:Streptozocin